ESC Premium Access

Controversies in management of atrial fibrillation and non-ischemic dilated cardiomyopathy

Event: ESC CONGRESS 2019
Topic: Arrhythmias, General
Session type: Debate Session
Date: 2 September 2019
Time: 08:30 - 09:40

Session

6 presentations in this session

Asymptomatic patients with atrial fibrillation should undergo ablation - PRO.

Speaker: Professor J. Kalman (Melbourne, AU)
Thumbnail

Asymptomatic patients with atrial fibrillation should undergo ablation - CON.

Speaker: Professor P. Sanders (Adelaide, AU)
Thumbnail

Asymptomatic patients with atrial fibrillation should undergo ablation - Discussion

Thumbnail

Patients with non-ischemic dilated cardiomyopathy still need primary prevention ICDs - PRO.

Speaker: Doctor S. Al-Khatib (Durham, US)
Thumbnail

Patients with non-ischemic dilated cardiomyopathy still need primary prevention ICDs - CON

Speaker: Professor L. Kober (Copenhagen, DK)
Thumbnail

Patients with non-ischemic dilated cardiomyopathy still need primary prevention ICDs - Discussion

Thumbnail

4 speakers from this session

Professor Jonathan Kalman

Royal Melbourne Hospital, Melbourne (Australia)
8 presentations
0 follower

Professor Prashanthan Sanders

University of Adelaide, Adelaide (Australia)
13 presentations
0 follower

Doctor Sana Al-Khatib

Duke University Medical Center, Durham (United States of America)
1 presentation
0 follower

Professor Lars Kober

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
17 presentations
0 follower

This platform is supported by

logo Novo Nordisk